Issue 2, 2007

Natural product growth inhibitors of Mycobacterium tuberculosis

Abstract

Covering: 2003–2005. Previous review: Nat. Prod. Rep., 2003, 20, 535–557

This review covers natural products (secondary metabolites) with reported growth inhibitory activity towards Mycobacterium tuberculosis or related organisms. Such compounds have been isolated from a variety of sources including terrestrial and marine plants and animals, and microorganisms, with the express intent of identifying novel scaffolds for the development of new antituberculosis agents. The literature from January 2003 to December 2005 (inclusive) is reviewed and 146 references to 353 compounds are cited. The compounds are presented in order of chemical type, namely lipids/fatty acids and simple aromatics, phenolics and quinones, peptides, alkaloids, terpenes (monoterpenoids, diterpenes, sesquiterpenes and triterpenes), steroids and miscellaneous structures.

Graphical abstract: Natural product growth inhibitors of Mycobacterium tuberculosis

Article information

Article type
Review Article
Submitted
02 Aug 2006
First published
28 Nov 2006

Nat. Prod. Rep., 2007,24, 278-297

Natural product growth inhibitors of Mycobacterium tuberculosis

B. R. Copp and A. N. Pearce, Nat. Prod. Rep., 2007, 24, 278 DOI: 10.1039/B513520F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements